TP53 and endometrial cancer: The current knowledge from The Cancer Genome Atlas defined four clinically distinct endometrial cancer types based on their p53 mutational burden, exonuclease domain of the DNA polymerase epsilon (POLE) mutations and microsatellite instability (Cancer Genome Atlas Research Network et al., 2013; Stelloo et al., 2016).